IL123595A - Hydrolysis-promoting taxane hydrophobic derivatives and pharmaceutical compositions containing them - Google Patents
Hydrolysis-promoting taxane hydrophobic derivatives and pharmaceutical compositions containing themInfo
- Publication number
- IL123595A IL123595A IL12359596A IL12359596A IL123595A IL 123595 A IL123595 A IL 123595A IL 12359596 A IL12359596 A IL 12359596A IL 12359596 A IL12359596 A IL 12359596A IL 123595 A IL123595 A IL 123595A
- Authority
- IL
- Israel
- Prior art keywords
- taxane
- hydrolysis
- promoting
- pharmaceutical compositions
- compositions containing
- Prior art date
Links
- 229940123237 Taxane Drugs 0.000 title abstract 6
- DKPFODGZWDEEBT-QFIAKTPHSA-N taxane Chemical class C([C@]1(C)CCC[C@@H](C)[C@H]1C1)C[C@H]2[C@H](C)CC[C@@H]1C2(C)C DKPFODGZWDEEBT-QFIAKTPHSA-N 0.000 title abstract 4
- 230000002209 hydrophobic effect Effects 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 239000004215 Carbon black (E152) Substances 0.000 abstract 2
- 229930195733 hydrocarbon Natural products 0.000 abstract 2
- 150000002430 hydrocarbons Chemical class 0.000 abstract 2
- 241001465754 Metazoa Species 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 230000007062 hydrolysis Effects 0.000 abstract 1
- 238000006460 hydrolysis reaction Methods 0.000 abstract 1
- 238000001727 in vivo Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 238000006467 substitution reaction Methods 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
- C07D305/14—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Dispersion Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Epoxy Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US357595P | 1995-09-12 | 1995-09-12 | |
| PCT/US1996/014631 WO1997010234A1 (en) | 1995-09-12 | 1996-09-12 | Hydrolysis-promoting taxane hydrophobic derivatives |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL123595A0 IL123595A0 (en) | 1998-10-30 |
| IL123595A true IL123595A (en) | 2000-10-31 |
Family
ID=21706522
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL12359596A IL123595A (en) | 1995-09-12 | 1996-09-12 | Hydrolysis-promoting taxane hydrophobic derivatives and pharmaceutical compositions containing them |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US5703117A (de) |
| EP (1) | EP0902783B1 (de) |
| JP (1) | JP4192208B2 (de) |
| KR (1) | KR100401220B1 (de) |
| CN (1) | CN1100770C (de) |
| AT (2) | ATE216377T1 (de) |
| CA (1) | CA2231750C (de) |
| CZ (1) | CZ288562B6 (de) |
| DE (2) | DE69635428T2 (de) |
| DK (2) | DK1229030T3 (de) |
| ES (2) | ES2179208T3 (de) |
| HU (1) | HU226325B1 (de) |
| IL (1) | IL123595A (de) |
| MX (1) | MX9801871A (de) |
| NO (1) | NO319521B1 (de) |
| NZ (1) | NZ318300A (de) |
| PL (1) | PL187738B1 (de) |
| PT (1) | PT902783E (de) |
| SK (1) | SK283199B6 (de) |
| TR (1) | TR199800443T1 (de) |
| WO (1) | WO1997010234A1 (de) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6107332A (en) * | 1995-09-12 | 2000-08-22 | The Liposome Company, Inc. | Hydrolysis-promoting hydrophobic taxane derivatives |
| US6667053B1 (en) * | 1996-02-16 | 2003-12-23 | Elan Pharmaceuticals, Inc. | D and L etherlipid stereoisomers and liposomes |
| US5912264A (en) * | 1997-03-03 | 1999-06-15 | Bristol-Myers Squibb Company | 6-halo-or nitrate-substituted paclitaxels |
| US8853260B2 (en) | 1997-06-27 | 2014-10-07 | Abraxis Bioscience, Llc | Formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof |
| CA2309652C (en) | 1997-11-10 | 2013-01-29 | Memorial Sloan-Kettering Cancer Center | Process for producing arsenic trioxide formulations and methods for treating cancer using arsenic trioxide or melarsoprol |
| BR9911031A (pt) * | 1998-05-20 | 2002-01-29 | Liposome Co Inc | Novas formulações em partìculas |
| US7314637B1 (en) | 1999-06-29 | 2008-01-01 | Neopharm, Inc. | Method of administering liposomal encapsulated taxane |
| US6146659A (en) * | 1998-07-01 | 2000-11-14 | Neopharm, Inc. | Method of administering liposomal encapsulated taxane |
| ATE247465T1 (de) * | 1999-01-12 | 2003-09-15 | Quanam Medical Corp | Arzneimittel und verfahren zur verabreichung von wasserunlöslichen paclitaxelderivaten |
| HK1049787B (en) | 1999-10-01 | 2014-07-25 | Immunogen, Inc. | Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents |
| AU7007001A (en) | 2000-06-22 | 2002-01-02 | Nitromed Inc | Nitrosated and nitrosylated taxanes, compositions and methods of use |
| US6607689B1 (en) * | 2000-08-29 | 2003-08-19 | Micron Technology, Inc. | Layer thickness control for stereolithography utilizing variable liquid elevation and laser focal length |
| EP1304103B1 (de) * | 2001-10-22 | 2008-12-31 | Viroblock SA | Non-phospholipid Vesikel (npLV) und ihre Verwendung in kosmetischen, therapeutischen und prophylaktischen Anwendungen |
| AU2002351169B2 (en) * | 2001-11-26 | 2007-09-20 | Intas Pharmaceuticals Limited | Method for preparing and using polyoxyethylated castor oil in pharmaceutical compositions |
| JP2005534718A (ja) * | 2002-06-26 | 2005-11-17 | メディゲーネ オンコロギー ゲゼルシャフト ミット ベシュレンクテル ハフツング | カチオンキャリヤー系において診断化合物および治療化合物を安定化させる新規方法 |
| KR20050105451A (ko) | 2003-02-03 | 2005-11-04 | 네오팜 인코포레이티드 | 안정한 멸균 여과가능한 리포좀 캡슐화 탁산 및 다른항종양제 |
| CA2598213C (en) * | 2005-02-18 | 2011-04-19 | Abraxis Bioscience, Inc. | Drugs with improved hydrophobicity for incorporation in medical devices |
| CA2603987A1 (en) | 2005-04-12 | 2006-10-19 | Wisconsin Alumni Research Foundation | Micelle composition of polymer and passenger drug |
| WO2009126401A1 (en) * | 2008-04-10 | 2009-10-15 | Abraxis Bioscience, Llc | Compositions of hydrophobic taxane derivatives and uses thereof |
| KR20100133475A (ko) * | 2008-04-10 | 2010-12-21 | 아브락시스 바이오사이언스, 엘엘씨 | 소수성 탁산 유도체의 조성물 그의 용도 |
| KR101721281B1 (ko) | 2009-09-25 | 2017-04-10 | 위스콘신 얼럼나이 리서어치 화운데이션 | 치료제의 미셀 캡슐화 |
| CN105503844A (zh) * | 2015-12-11 | 2016-04-20 | 上海大学 | C-13和c-7位结构改造的紫杉醇类化合物及其制备方法 |
| CN111004195B (zh) * | 2019-12-03 | 2022-01-28 | 沈阳药科大学 | 卡巴他赛弱碱性衍生物及其制剂 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5059699A (en) * | 1990-08-28 | 1991-10-22 | Virginia Tech Intellectual Properties, Inc. | Water soluble derivatives of taxol |
| US5278324A (en) * | 1990-08-28 | 1994-01-11 | Virginia Tech Intellectual Properties, Inc. | Water soluble derivatives of taxol |
| WO1994014787A1 (en) * | 1992-12-23 | 1994-07-07 | Bristol-Myers Squibb Company | Novel sidechain-bearing taxanes and intermediates thereof |
| IL108316A (en) * | 1993-01-15 | 2006-10-31 | Univ Florida State | C10 taxane derivatives and pharmaceutical compositions containing them |
| US5580899A (en) * | 1995-01-09 | 1996-12-03 | The Liposome Company, Inc. | Hydrophobic taxane derivatives |
-
1996
- 1996-09-12 JP JP51210297A patent/JP4192208B2/ja not_active Expired - Fee Related
- 1996-09-12 ES ES96930847T patent/ES2179208T3/es not_active Expired - Lifetime
- 1996-09-12 SK SK334-98A patent/SK283199B6/sk unknown
- 1996-09-12 PT PT96930847T patent/PT902783E/pt unknown
- 1996-09-12 AT AT96930847T patent/ATE216377T1/de not_active IP Right Cessation
- 1996-09-12 WO PCT/US1996/014631 patent/WO1997010234A1/en not_active Ceased
- 1996-09-12 PL PL96325477A patent/PL187738B1/pl not_active IP Right Cessation
- 1996-09-12 NZ NZ318300A patent/NZ318300A/xx unknown
- 1996-09-12 TR TR1998/00443T patent/TR199800443T1/xx unknown
- 1996-09-12 CA CA002231750A patent/CA2231750C/en not_active Expired - Fee Related
- 1996-09-12 AT AT02008590T patent/ATE309235T1/de not_active IP Right Cessation
- 1996-09-12 ES ES02008590T patent/ES2252347T3/es not_active Expired - Lifetime
- 1996-09-12 US US08/712,684 patent/US5703117A/en not_active Expired - Fee Related
- 1996-09-12 HU HU9901433A patent/HU226325B1/hu unknown
- 1996-09-12 DK DK02008590T patent/DK1229030T3/da active
- 1996-09-12 CN CN96198237A patent/CN1100770C/zh not_active Expired - Fee Related
- 1996-09-12 DK DK96930847T patent/DK0902783T3/da active
- 1996-09-12 IL IL12359596A patent/IL123595A/xx not_active IP Right Cessation
- 1996-09-12 DE DE69635428T patent/DE69635428T2/de not_active Expired - Fee Related
- 1996-09-12 DE DE69620802T patent/DE69620802T2/de not_active Expired - Fee Related
- 1996-09-12 KR KR10-1998-0701653A patent/KR100401220B1/ko not_active Expired - Fee Related
- 1996-09-12 EP EP96930847A patent/EP0902783B1/de not_active Expired - Lifetime
- 1996-09-12 MX MX9801871A patent/MX9801871A/es not_active IP Right Cessation
- 1996-09-12 CZ CZ1998711A patent/CZ288562B6/cs not_active IP Right Cessation
-
1998
- 1998-03-11 NO NO19981071A patent/NO319521B1/no unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL123595A (en) | Hydrolysis-promoting taxane hydrophobic derivatives and pharmaceutical compositions containing them | |
| IL133585A0 (en) | Soluble prodrugs of paclitaxel | |
| EP0693924A4 (de) | Verfahren für die in-vivo-verabreichung von biologischen substanzen und hierfür verwendbare zusammensetzungen | |
| CA2301057A1 (en) | A method of administering liposomal encapsulated taxane | |
| SE9301951D0 (sv) | Methods for administration of taxol | |
| MX9203543A (es) | Medicamento. | |
| AU1406895A (en) | Inhalable contrast agent | |
| NZ312715A (en) | Novel camptothecin analogues, preparation methods therefor, use thereof as drugs, and pharmaceutical compositions containing said analogues | |
| DK0975595T3 (da) | Kokainanaloger | |
| DE69631975D1 (de) | Discodermolide verbindungen und deren pharmazeutische zusammensetzungen zur krebstherapie | |
| SE8404283D0 (sv) | Anvendning av ett specifikt tumorassocierat antigen, nemligen sialosyllaktotetraos, for diagnostiska och terapeutiska forfaranden vid cancersjukdomar | |
| GB1515241A (en) | Beta-lactam antibiotics | |
| FR2616330B1 (fr) | Agent actif et medicament en contenant destines a prevenir ou a combattre le rejet de greffe d'organe chez l'homme | |
| DE68927055D1 (de) | 2',5'-oligoadenylat-derivate zur verwendung als heilmittel | |
| EP1229030A3 (de) | Hydrolyse-einleitende hydrophobe Taxane Derivate | |
| IL112668A (en) | 4-Amino 6-substituted mycophenolic acid and derivatives thereof their preparation and pharmaceutical compositions containing them | |
| GR3034062T3 (en) | Utilization of efaroxan and derivatives thereof for the preparation of a medicament intended to the treatment of parkinson disease | |
| DE69233773D1 (de) | Verwendung von topotecan zur herstellung eines medikaments zur verwendung in der behandlung von ovarialkrebs | |
| UA10301A (uk) | Спосіб лікуваhhя раку шлуhку | |
| HUT41778A (en) | Process for producing ergoline derivatives | |
| MX9709684A (es) | Uso de derivados de vitamina d4 para tratamiento de trastornos de la piel. | |
| NZ335189A (en) | Use of taxane hydrophobic derivatives for the treatment of cancer |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FF | Patent granted | ||
| KB | Patent renewed | ||
| KB | Patent renewed | ||
| KB | Patent renewed | ||
| MM9K | Patent not in force due to non-payment of renewal fees |